Location: 101 Mississippi St., San Francisco, California, United States United States
Founded in: 2015
Stage: Pre-launch
Number of employees: 1-5
Funding history:
- Date: 01/2016, Seed: $700 k (post valuation: undisclosed amount).
Investors: Albert Azout
Short URL:
Awards and mentions
Received $309,000 award from The Small Business Innovation Research (SBIR) program.


San Francisco, California, United States United States
  • About
  • >
  • Activities
Company description

Provider of hardware and software used to monitor patient's risk of heart failure. The company provides digital health software and hardware intended to give actionable data for the management of congestive heart failure. 


Business model

The device users are patients suffering from congestive heart failure (CHF). Our solution, once FDA approved, will be prescribed to these individuals by a physician for remote patient monitoring, and we will bill insurance / Center for Medicare Services a monthly subscription fee per patient.

Competitive advantage

The Respirix solution is non-invasive and we aim to facilitate remote, at-home monitoring of CHF patients at a substantially lower cost than our competitors, without requiring a surgical procedure, and with equivalent or superior accuracy.

Investor Deafult Image
Synergy Ventures - Unconfirmed
Albert Azout
Founder @ Level Ventures, Partner @Cota Capital, Co-Founder @ Attached. Cota Capital Babson College
Investor Deafult Image
Signatures Capital - Unconfirmed